This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
| adjective | noun | frequency |
|---|---|---|
| - | cov-2 | 533 |
| covid-19 | patients | 128 |
| novel | coronavirus | 125 |
| respiratory | syndrome | 116 |
| covid-19 | infection | 89 |
| covid-19 | pandemic | 67 |
| - | analysis | 41 |
| - | risk | 36 |
| immune | system | 36 |
| higher | risk | 31 |
| severe | disease | 30 |
| viral | infection | 29 |
| cardiovascular | disease | 24 |
| covid-19 | cases | 20 |
| viral | infections | 19 |
| new | coronavirus | 19 |
| respiratory | symptoms | 18 |
| retrospective | study | 16 |
| - | hospital | 15 |
| - | infection | 15 |
| respiratory | system | 14 |
| - | cancer | 13 |
| high | risk | 13 |
| human | coronavirus | 12 |
| severe | cases | 12 |
| immune | cells | 12 |
| respiratory | disease | 12 |
| - | time | 12 |
| - | coronavirus | 12 |
| - | cell | 12 |
| cardiovascular | diseases | 11 |
| covid-19 | patient | 10 |
| many | patients | 10 |
| severe | covid-19 | 10 |
| covid-19 | symptoms | 9 |
| new | cases | 9 |
| inflammatory | syndrome | 8 |
| retrospective | studies | 8 |
| severe | patients | 8 |
| first | case | 8 |
| covid-19 | disease | 8 |
| clinical | data | 8 |
| asymptomatic | patients | 7 |
| cardiovascular | system | 7 |
| common | symptoms | 7 |
| severe | coronavirus | 7 |
| - | sars | 6 |
| asymptomatic | covid-19 | 6 |
| first | time | 6 |
| positive | patients | 6 |
| respiratory | infections | 6 |
| respiratory | viruses | 6 |
| retrospective | case | 6 |
| many | cases | 5 |
| negative | sars | 5 |
| retrospective | analysis | 5 |
| human | cells | 5 |
| early | treatment | 5 |
| older | patients | 5 |
| - | patient | 4 |
| more | cases | 4 |
| asymptomatic | cases | 4 |
| significant | risk | 4 |
| respiratory | infection | 4 |
| respiratory | diseases | 4 |
| positive | tests | 4 |
| negative | test | 4 |
| such | cases | 4 |
| medical | treatment | 4 |
| earlier | virus | 4 |
| earlier | studies | 4 |
| clinical | symptoms | 4 |
| clinical | studies | 4 |
| clinical | case | 4 |
| first | cases | 4 |
| positive | cases | 3 |
| novel | virus | 3 |
| other | patients | 3 |
| other | studies | 3 |
| other | systems | 3 |
| other | treatments | 3 |
| respiratory | coronavirus | 3 |
| positive | sars | 3 |
| positive | test | 3 |
| respiratory | virus | 3 |
| severe | case | 3 |
| severe | infections | 3 |
| new | infection | 3 |
| new | virus | 3 |
| high | case | 3 |
| more | patients | 3 |
| asymptomatic | infection | 3 |
| many | studies | 3 |
| - | covid-19 | 3 |
| - | virus | 3 |
| acute | care | 3 |
| acute | infection | 3 |
| - | case | 3 |
| asymptomatic | infections | 3 |
| asymptomatic | sars | 3 |
| covid-19 | infections | 3 |
| first | symptom | 3 |
| first | test | 3 |
| other | hospitals | 2 |
| viral | therapy | 2 |
| viral | proteins | 2 |
| viral | diseases | 2 |
| such | pandemics | 2 |
| such | antibody | 2 |
| severe | sars | 2 |
| severe | patient | 2 |
| severe | pandemic | 2 |
| other | viruses | 2 |
| other | tests | 2 |
| other | risk | 2 |
| negative | tests | 2 |
| clinical | cases | 2 |
| - | antibodies | 2 |
| - | care | 2 |
| - | protein | 2 |
| clinical | analysis | 2 |
| - | study | 2 |
| clinical | syndrome | 2 |
| covid-19 | test | 2 |
| covid-19 | treatment | 2 |
| covid-19 | virus | 2 |
| first | symptoms | 2 |
| new | treatment | 1 |
| negative | antibody | 1 |
| negative | patients | 1 |
| new | covid-19 | 1 |
| new | studies | 1 |
| novel | syndrome | 1 |
| new | treatments | 1 |
| novel | disease | 1 |
| novel | infection | 1 |
| novel | sars | 1 |
| medical | treatments | 1 |
| more | studies | 1 |
| inflammatory | proteins | 1 |
| medical | therapy | 1 |
| medical | therapies | 1 |
| medical | patients | 1 |
| many | cancer | 1 |
| lower | risk | 1 |
| older | studies | 1 |
| inflammatory | diseases | 1 |
| inflammatory | cell | 1 |
| immune | therapy | 1 |
| immune | studies | 1 |
| immune | cell | 1 |
| old | patient | 1 |
| other | cell | 1 |
| other | antibodies | 1 |
| other | antibody | 1 |
| such | treatments | 1 |
| such | system | 1 |
| such | symptoms | 1 |
| such | diseases | 1 |
| such | analyses | 1 |
| significant | symptoms | 1 |
| severe | symptoms | 1 |
| severe | diseases | 1 |
| retrospective | data | 1 |
| respiratory | syndromes | 1 |
| respiratory | data | 1 |
| respiratory | case | 1 |
| positive | patient | 1 |
| positive | covid-19 | 1 |
| positive | cancers | 1 |
| other | therapies | 1 |
| other | tested | 1 |
| other | symptoms | 1 |
| other | hospital | 1 |
| other | diseases | 1 |
| human | sars | 1 |
| other | cases | 1 |
| other | case | 1 |
| human | studies | 1 |
| human | cancer | 1 |
| human | protein | 1 |
| human | patients | 1 |
| common | risk | 1 |
| common | infection | 1 |
| common | diseases | 1 |
| common | covid-19 | 1 |
| common | coronavirus | 1 |
| common | antibody | 1 |
| clinical | treatment | 1 |
| clinical | therapies | 1 |
| clinical | test | 1 |
| clinical | study | 1 |
| asymptomatic | virus | 1 |
| asymptomatic | disease | 1 |
| acute | patients | 1 |
| acute | hospital | 1 |
| acute | diseases | 1 |
| acute | disease | 1 |
| - | test | 1 |
| - | systems | 1 |
| - | patients | 1 |
| - | pandemic | 1 |
| - | infections | 1 |
| - | cells | 1 |
| - | analyses | 1 |
| common | symptom | 1 |
| covid-19 | case | 1 |
| covid-19 | coronavirus | 1 |
| first | hospital | 1 |
| human | infections | 1 |
| human | infection | 1 |
| human | disease | 1 |
| human | antibodies | 1 |
| highest | risk | 1 |
| higher | risks | 1 |
| high | antibody | 1 |
| first | treatment | 1 |
| first | sars | 1 |
| first | patient | 1 |
| first | days | 1 |
| covid-19 | hospital | 1 |
| first | day | 1 |
| first | data | 1 |
| first | covid-19 | 1 |
| early | symptoms | 1 |
| early | infection | 1 |
| early | covid-19 | 1 |
| early | cases | 1 |
| earlier | study | 1 |
| covid-19 | treatments | 1 |
| covid-19 | symptom | 1 |
| viral | disease | 1 |